{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:42:57Z","timestamp":1793090577633,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.urology.2025.06.030","type":"journal-article","created":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T01:29:26Z","timestamp":1749950966000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development and External Validation of a Local Pelvic Recurrence Risk Score After Radical Cystectomy: Identifying the Ideal Candidate for Adjuvant Radiation Clinical Trials"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5583-9749","authenticated-orcid":false,"given":"Matthew S.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron J.","family":"Britton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Longoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Tarrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"Traughber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Stish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob J.","family":"Orme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paras H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00a0Jeffrey","family":"Karnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2025.06.030_bib1","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urology.2025.06.030_bib2","unstructured":"Bladder Cancer Prognosis and Survival Rates - NCI. Accessed November 20, 2023. \u3008https:\/\/www.cancer.gov\/types\/bladder\/survival\u3009."},{"key":"10.1016\/j.urology.2025.06.030_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00345-012-0936-8","article-title":"Patterns of local recurrence after radical cystectomy in a contemporary series of patients with muscle-invasive bladder cancer","volume":"30","author":"Cornu","year":"2012","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2025.06.030_bib4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jjco\/hyn036","article-title":"The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer","volume":"38","author":"Ide","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urology.2025.06.030_bib5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.urology.2004.05.003","article-title":"Local recurrence after radical cystectomy for invasive bladder cancer: An analysis of predictive factors","volume":"64","author":"Honma","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urology.2025.06.030_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00345-017-2115-4","article-title":"Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature","volume":"36","author":"Mari","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2025.06.030_bib7","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1464-410X.2011.10455.x","article-title":"Factors influencing post-recurrence survival in bladder cancer following radical cystectomy","volume":"109","author":"Mitra","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2025.06.030_bib8","first-page":"3773","article-title":"Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for focally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II","volume":"11","author":"Kurahashi","year":"2005","journal-title":"Clin\u00a0Cancer Res"},{"key":"10.1016\/j.urology.2025.06.030_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JU.0000000000003981","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/SUO Guideline (2017; Amended 2020, 2024)","volume":"212","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.06.030_bib10","unstructured":"Witjes J., Bruins H., Carri\u00f3n A., et al. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Published online 2024. Accessed September 1, 2024. \u3008https:\/\/uroweb.org\/guidelines\/muscle-invasive-and-metastatic-bladder-cancer\u3009."},{"key":"10.1016\/j.urology.2025.06.030_bib11","first-page":"511","article-title":"Postoperative radiotherapy of carcinoma in bilharzial bladder: Improved disease free survival through improving local control","volume":"23","author":"Zaghloul","year":"1992","journal-title":"Int\u00a0J\u00a0Radiat\u00a0Oncol\u00a0Biol Phys"},{"key":"10.1016\/j.urology.2025.06.030_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.4591","article-title":"Adjuvant sandwich chemotherapy plus radiotherapy vs adjuvant chemotherapy alone for locally advanced bladder cancer after radical cystectomy: a randomized phase 2 trial","volume":"153","author":"Zaghloul","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.urology.2025.06.030_bib13","first-page":"659","article-title":"The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: a\u00a0systematic review","volume":"37","author":"Iwata","year":"2019","journal-title":"Urol\u00a0Oncol Semin\u00a0Orig\u00a0Investig"},{"key":"10.1016\/j.urology.2025.06.030_bib14","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/cncr.28544","article-title":"Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710","volume":"120","author":"Christodouleas","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2025.06.030_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clgc.2018.09.008","article-title":"Development of a prediction tool for exclusive locoregional recurrence after radical cystectomy in patients with muscle-invasive bladder cancer","volume":"17","author":"Necchi","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urology.2025.06.030_bib16","first-page":"672.e1","article-title":"Predicting local failure after radical cystectomy in patients with bladder cancer:\u00a0implications for the selection of candidates at adjuvant radiation therapy","volume":"35","author":"Moschini","year":"2017","journal-title":"Urol\u00a0Oncol Semin\u00a0Orig\u00a0Investig"},{"key":"10.1016\/j.urology.2025.06.030_bib17","first-page":"496.e9","article-title":"Locoregional recurrence after cystectomy in muscle invasive bladder cancer: implications for adjuvant radiotherapy","volume":"39","author":"Murthy","year":"2021","journal-title":"Urol\u00a0Oncol Semin\u00a0Orig\u00a0Investig"},{"key":"10.1016\/j.urology.2025.06.030_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ctrv.2018.07.011","article-title":"Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: a\u00a0systematic-review and framework for adjuvant radiotherapy","volume":"70","author":"Sargos","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.urology.2025.06.030_bib19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.kjms.2014.03.011","article-title":"Local and systemic recurrence patterns of urothelial cancer after radical cystectomy","volume":"30","author":"\u00d6zbir","year":"2014","journal-title":"Kaohsiung J\u00a0Med\u00a0Sci"},{"key":"10.1016\/j.urology.2025.06.030_bib20","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0022-5347(05)65284-6","article-title":"Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer","volume":"167","author":"Herr","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.06.030_bib21","first-page":"81","article-title":"A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy","volume":"85","author":"Baumann","year":"2013","journal-title":"Int\u00a0J\u00a0Radiat\u00a0Oncol Biol Phys"},{"key":"10.1016\/j.urology.2025.06.030_bib22","first-page":"1206","article-title":"Standard or extended lymphadenectomy for muscle-invasive bladder cancer","volume":"391","author":"Lerner","year":"2024","journal-title":"N\u00a0Eng\u00a0J\u00a0Med"},{"key":"10.1016\/j.urology.2025.06.030_bib23","first-page":"2781","article-title":"Surgical factors influence bladder cancer outcomes: a\u00a0cooperative group report","volume":"22","author":"Herr","year":"2004","journal-title":"J\u00a0Clin\u00a0Oncol"},{"key":"10.1016\/j.urology.2025.06.030_bib24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1464-410x.2000.00614.x","article-title":"Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis","volume":"85","author":"Leissner","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2025.06.030_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clgc.2020.06.004","article-title":"Role of neoadjuvant chemotherapy in squamous variant histology in urothelial bladder cancer: does presence and percentage matter?","volume":"19","author":"Speir","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urology.2025.06.030_bib26","first-page":"2171","article-title":"International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial","volume":"29","author":"Trialists IC of, Group the EO for R and T of CGUTC, Group the ABCS, Group the NCI of CCT, Finnbladder NBCSG, Group CUE de TO","year":"2011","journal-title":"J\u00a0Clin\u00a0Oncol"},{"key":"10.1016\/j.urology.2025.06.030_bib27","doi-asserted-by":"crossref","unstructured":"M.S. Zaghloul, J.P. Christodouleas, W.T. Hwang\u00a0et al. Randomized phase III trial of adjuvant sequential chemotherapy plus radiotherapy versus adjuvant radiotherapy alone for locally advanced bladder cancer after radical cystectomy: Urothelial carcinoma subgroup analysis.\u00a0351-351https:\/\/doi. org\/101200\/JCO2019377_suppl351 37 7_ 2019 doi:\u00a010.1200\/JCO.2019.37.7_SUPPL.351.","DOI":"10.1200\/JCO.2019.37.7_suppl.351"},{"key":"10.1016\/j.urology.2025.06.030_bib28","first-page":"658","article-title":"The value and safety of adjuvant radiation therapy after radical cystectomy in locally advanced urothelial bladder cancer: a controlled randomized study","volume":"120","author":"Zaghloul","year":"2024","journal-title":"Int\u00a0J\u00a0Radiat\u00a0Oncol Biol Phys"},{"key":"10.1016\/j.urology.2025.06.030_bib29","doi-asserted-by":"crossref","unstructured":"M.S. Zaghloul, J.P. Christodouleas, T. Zaghloul,\u00a0et al. Randomized trial of adjuvant chemotherapy versus adjuvant radiation therapy for locally advanced bladder cancer after radical cystectomy. 4507-4507https:\/\/doi. org\/101200\/JCO20193715_suppl4507. 37(15_) 2019. doi:\u00a010.1200\/JCO.2019.37.15_SUPPL.4507.","DOI":"10.1200\/JCO.2019.37.15_suppl.4507"},{"key":"10.1016\/j.urology.2025.06.030_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/BLC-180163","article-title":"The role of adjuvant radiation therapy in locally advanced bladder cancer","volume":"4","author":"Lewis","year":"2018","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.urology.2025.06.030_bib31","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0022-5347(01)66693-X","article-title":"The relationship of local control to distant metastasis in muscle invasive bladder cancer","volume":"154","author":"Pollack","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.06.030_bib32","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.juro.2007.08.023","article-title":"Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival","volume":"178","author":"Dotan","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.06.030_bib33","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2025.06.030_bib34","first-page":"45","article-title":"Adjuvant pembrolizumab versus observation in muscle-invasive urothelial carcinoma","volume":"392","author":"Apolo","year":"2024","journal-title":"N\u00a0Eng\u00a0J\u00a0Med"},{"key":"10.1016\/j.urology.2025.06.030_bib35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(21)00004-8","article-title":"Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Bellmunt","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urology.2025.06.030_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euo.2018.09.013","article-title":"Combining immunotherapy with radiotherapy for the treatment of genitourinary malignancies","volume":"2","author":"Solanki","year":"2019","journal-title":"Eur Urol Oncol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429525006016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429525006016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:33:30Z","timestamp":1778664810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429525006016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":36,"alternative-id":["S0090429525006016"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2025.06.030","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and External Validation of a Local Pelvic Recurrence Risk Score After Radical Cystectomy: Identifying the Ideal Candidate for Adjuvant Radiation Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2025.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}